162 related articles for article (PubMed ID: 38875411)
1. Malaria vaccination in Africa: A mini-review of challenges and opportunities.
Olawade DB; Wada OZ; Ezeagu CN; Aderinto N; Balogun MA; Asaolu FT; David-Olawade AC
Medicine (Baltimore); 2024 Jun; 103(24):e38565. PubMed ID: 38875411
[TBL] [Abstract][Full Text] [Related]
2. Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review.
Dimala CA; Kika BT; Kadia BM; Blencowe H
PLoS One; 2018; 13(12):e0209744. PubMed ID: 30596732
[TBL] [Abstract][Full Text] [Related]
3. Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa.
Leach A; Vekemans J; Lievens M; Ofori-Anyinam O; Cahill C; Owusu-Agyei S; Abdulla S; Macete E; Njuguna P; Savarese B; Loucq C; Ballou WR;
Malar J; 2011 Aug; 10():224. PubMed ID: 21816029
[TBL] [Abstract][Full Text] [Related]
4. Challenges in malaria control in sub-Saharan Africa: the vaccine perspective.
Lusingu JP; Von Seidlein L
Tanzan J Health Res; 2008 Oct; 10(4):253-66. PubMed ID: 19402588
[TBL] [Abstract][Full Text] [Related]
5. Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study.
Sauboin CJ; Van Bellinghen LA; Van De Velde N; Van Vlaenderen I
Malar J; 2015 Dec; 14():524. PubMed ID: 26702637
[TBL] [Abstract][Full Text] [Related]
6. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
Breman JG; Alilio MS; Mills A
Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
[TBL] [Abstract][Full Text] [Related]
7. Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in sub-Saharan Africa.
Maire N; Tediosi F; Ross A; Smith T
Am J Trop Med Hyg; 2006 Aug; 75(2 Suppl):111-8. PubMed ID: 16931822
[TBL] [Abstract][Full Text] [Related]
8. The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models.
Penny MA; Galactionova K; Tarantino M; Tanner M; Smith TA
BMC Med; 2015 Jul; 13():170. PubMed ID: 26219380
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. RTS,S/AS01E malaria vaccine (MoSQUIRIX*) Children living in malaria-endemic regions: little efficacy, poorly documented harms.
Prescrire Int; 2017 Jan; 26(178):5-8. PubMed ID: 30730633
[TBL] [Abstract][Full Text] [Related]
11. New tools for malaria control - using them wisely.
Greenwood B
J Infect; 2017 Jun; 74 Suppl 1():S23-S26. PubMed ID: 28646958
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage.
Unwin HJT; Mwandigha L; Winskill P; Ghani AC; Hogan AB
Malar J; 2021 Nov; 20(1):438. PubMed ID: 34789253
[TBL] [Abstract][Full Text] [Related]
13. Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11.
van Eijk AM; Hill J; Larsen DA; Webster J; Steketee RW; Eisele TP; ter Kuile FO
Lancet Infect Dis; 2013 Dec; 13(12):1029-42. PubMed ID: 24054085
[TBL] [Abstract][Full Text] [Related]
14. [Malaria vaccines--which vaccines to whom?].
Jepsen S
Tidsskr Nor Laegeforen; 2000 May; 120(14):1665-8. PubMed ID: 10901079
[TBL] [Abstract][Full Text] [Related]
15. Measuring and characterizing night time human behaviour as it relates to residual malaria transmission in sub-Saharan Africa: a review of the published literature.
Monroe A; Moore S; Koenker H; Lynch M; Ricotta E
Malar J; 2019 Jan; 18(1):6. PubMed ID: 30634963
[TBL] [Abstract][Full Text] [Related]
16. Relationship between changing malaria burden and low birth weight in sub-Saharan Africa: A difference-in-differences study via a pair-of-pairs approach.
Heng S; O'Meara WP; Simmons RA; Small DS
Elife; 2021 Jul; 10():. PubMed ID: 34259625
[TBL] [Abstract][Full Text] [Related]
17. [Development of anti-malarial vaccines and need for clinical trials in accordance with international standards in South Africa].
Doumbo OK; Djimdé AA; Théra MA
Bull Soc Pathol Exot; 2008 Jun; 101(3):249-53. PubMed ID: 18681219
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of malaria control in sub-Saharan Africa.
Goodman CA; Coleman PG; Mills AJ
Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
[TBL] [Abstract][Full Text] [Related]
19. Community readiness and acceptance for the implementation of a novel malaria vaccine among at-risk children in sub-saharan Africa: a systematic review protocol.
Kigongo E; Kabunga A; Opollo MS; Tumwesigye R; Musinguzi M; Akello AR; Nabaziwa J; Hardido TG; Puleh SS
Malar J; 2024 Jun; 23(1):182. PubMed ID: 38858779
[TBL] [Abstract][Full Text] [Related]
20. The evidence base on the cost-effectiveness of malaria control measures in Africa.
Goodman CA; Mills AJ
Health Policy Plan; 1999 Dec; 14(4):301-12. PubMed ID: 10787646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
